Depression is associated with increased C-reactive protein levels in patients with heart failure and hyperuricemia

Yu Wang,Yuzhi Zhen,Jianlong Zhai,Danping Wu,Kunshen Liu,Qingzhen Zhao,Chao Liu

DOI: https://doi.org/10.11909/j.issn.1671-5411.2017.04.010

2017-04-01

Journal of Geriatric Cardiology

Abstract:Psychological depression is considered a major determinant of health status in patients with heart failure (HF). The incidence of depression in HF is four to five times higher than that in the general population. HF and depression share common pathophysiological features, which include stimulation of the hypothalamus-pituitary-adrenal (HPA) axis and sympathetic activity, and elevated levels of pro-inflammatory cytokines. Over the past decades, growing evidence implicates inflammation activation, as an important pathway, is involved in disease progression in chronic HF. High sensitivity C-reactive protein (hs-CRP), an inflammation cytokine, exerts a detrimental effect on the cardiovascular systems, such as cardiac fibroblasts, myocytes, and vascular cells, by amplifying the inflammatory responsible for adverse ventricular remodeling. Similarly, the link between inflammation and depression also has been well documented over the past two decades. A large amount of evidence shows that subjects with depression have increased level of hs-CRP compared with those without depression. In patients with HF and hyperuricemia, an elevation in uric acid (UA) is associated with impaired renal function and increased increases oxidative stress, resulting in bigger inflammatory burden. However, whether the link between hs-CRP and depression still exists in such population remains unclear. Therefore, we conducted this cross-sectional study to assess the association between hs-CRP and depression patients with HF and hyperuricemia.  The protocol of this cross-sectional study was approved by the institutional ethics committee. This study complied with the Declaration of Helsinki. Inclusion criteria were adult HF patients with New York Heart Association (NYHA) function Class II-IV and systolic dysfunction (left ventricular ejection fraction  45%) and serum uric acid > 7 mg/dL